MedTrace Logo

Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function

NCT04097327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2020-01-10

No results posted yet for this study

Summary

The aim of this prospective, uncontrolled clinical study is to evaluate the clinical effect of Ectoin® Dermatitis Cream-EHK02 on skin hydration and transepidermal water loss (TEWL) in subjects with atopic dermatitis after single and multiple applications. Furthermore, data concerning the subjective impression of the study preparation should be collected.

Conditions

  • Atopic Dermatitis Eczema

Interventions

OTHER

Ectoin Dermatitis Cream 7% (EHK02)

Application of Ectoin Dermatitis Cream in accordance with the instructions for use

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-23
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097327 on ClinicalTrials.gov